Noveko International to raise funds for pursuing its global growth objectives

NewsGuard 100/100 Score

Noveko International Inc. ("the Company") is pleased to announce that it has entered into an agreement with Desjardins Securities Inc. as lead Agent on behalf of a syndicate (collectively "the Agents") to raise approximately C$10 million of Units (the "Units") by way of a best efforts private placement (the "Offering"). Each Unit will consist of one Class A Share of the Company and one-half of one Class A Share purchase warrant. The Units will be priced in the context of the market.

The Units will be offered to qualified investors in each province of Canada and potentially in other jurisdictions pursuant to applicable private placement exemptions. The securities issued pursuant to the Offering will be subject to a 4 month hold period. The Offering will be subject to the usual conditions, and the receipt of all required regulatory approvals, including approval of the Toronto Stock Exchange.

The securities offered have not been registered, and will not be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements.

The net proceeds of the Offering will be used to pursue the Company's global growth objectives, namely, fund the expansion of its international distribution networks, develop its current IP portfolio, develop new innovative applications, expand its production capacity, and for working capital purposes.

Source:

NOVEKO INTERNATIONAL INC.

Posted in:

Tags:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.